National Stock Number
6650-00-962-2231
National Stock Number (NSN) 6650-00-962-2231, or NIIN 009622231, (spacer,optical element) was assigned June 1, 1966 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jul 02, 2005, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 22261. [A TUBULAR SHAPED ITEM DESIGNED TO MAINTAIN A PREDETERMINED DISTANCE BETWEEN OPTICAL ELEMENTS, SUCH AS LENSES, RETICLES, AND THE LIKE. THE BORE MAY BE STRAIGHT, TAPERED OR COUNTERBORED, AND MAY HAVE ANNULAR SERRATIONS TO CONVERGE OR DIVERGE LIGHT RAYS. THE SURFACES, WHICH MATE WITH THE OPTICS, ARE USUALLY CHAMFERED, CONCAVE, AND/OR HAVE A SPECIFIED FINISH DESIGNATION IN THE RANGE OF 1 TO 125 MICROINCHES ARITHMETICAL AVERAGE (AA). SEE ALSO SPACER, SLEEVE AND CELL, OPTICAL ELEMENT.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no data in the HMIRS and the NSN is in an FSC not generally suspected of containing hazardous materials. NSN 6650009622231 does not contain precious metals.
This NSN is associated to Schedule B 9018500000: other ophthalmic instruments and appliances and parts and accessories. The Schedule B End Use is listed as medicinal equipment. NAICS classification category 339112: surgical and medical instrument manufacturing.
This information was last updated on Jul 01, 2025.